Pathways for non-manufacturers to drive generic drug repurposing for cancer in the U.S.

• Κύριοι συγγραφείς: Devon Crittenden (Συγγραφέας), Raquel Gallagher (Συγγραφέας), Fernanda Milans del Bosch (Συγγραφέας), David M. Fox (Συγγραφέας), Laura B. Kleiman (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Frontiers Media S.A., 2024-10-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Repurposing generic drugs as new treatments for life-threatening diseases such as cancer is an exciting yet largely overlooked opportunity due to a lack of market-driven incentives. Nonprofit organizations and other non-manufacturers have been ramping up efforts to repurpose widely available generic...